Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors [clinicaltrials:NCT00024661]
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors [clinicaltrials:NCT00024661]
Bio2RDF identifier
NCT00024661
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00024661
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
LErafAON is a liposome ...... patient will not be allowed.
brief title [clinicaltrials_vocabulary:brief-title]
Study to Determine the Maximum ...... nts With Advanced Solid Tumors
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2004-10-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... ded to 6
if DLT occurs.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-09-24T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
liposomes containing AON to c-raf protein (LErafAON)
recurrent solid tumors
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-04-12T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00024661
official title [clinicaltrials_vocabulary:official-title]
Study to Determine the Maximum ...... nts With Advanced Solid Tumors
org study id [clinicaltrials_vocabulary:org-study-id]
LErafAON-002
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2001-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2011-04-01T00:00:00Z
identifier
clinicaltrials:NCT00024661
title
Study to Determine the Maximum ...... nts With Advanced Solid Tumors
@en
type
label
Study to Determine the Maximum ...... s [clinicaltrials:NCT00024661]
@en